Neuraminidase inhibitors for influenza - PubMed (original) (raw)

Review

. 2005 Sep 29;353(13):1363-73.

doi: 10.1056/NEJMra050740.

Affiliations

• PMID: 16192481
• DOI: 10.1056/NEJMra050740

Free article

Review

Neuraminidase inhibitors for influenza

Anne Moscona. N Engl J Med. 2005.

Free article

No abstract available

PubMed Disclaimer

Similar articles

• [Neuraminidase inhibitor].
  Kaji M. Kaji M. Nihon Rinsho. 2000 Nov;58(11):2293-8. Nihon Rinsho. 2000. PMID: 11225320 Review. Japanese.
• [New diagnostic possibilities and medications. Fit for influenza?].
  Wutzler P. Wutzler P. MMW Fortschr Med. 2002 Nov 28;144(48):18. MMW Fortschr Med. 2002. PMID: 12532540 German. No abstract available.
• Two neuraminidase inhibitors for treatment of influenza.
  [No authors listed] [No authors listed] Med Lett Drugs Ther. 1999 Oct 8;41(1063):91-3. Med Lett Drugs Ther. 1999. PMID: 10535051 No abstract available.
• Neuraminidase inhibitors slightly beneficial for shortening flu symptoms.
  Phillips TG. Phillips TG. J Fam Pract. 2003 Oct;52(10):747-8. J Fam Pract. 2003. PMID: 14529590 No abstract available.
• Neuraminidase inhibitors for treatment of influenza.
  Ebell MH. Ebell MH. Am Fam Physician. 2004 Jun 15;69(12):2824. Am Fam Physician. 2004. PMID: 15222647 Review. No abstract available.

Cited by

• Influenza virus A(H1N1)pdm09 hemagglutinin polymorphism and associated disease in southern Germany during the 2010/11 influenza season.
  Falcone V, Bierbaum S, Kern W, Kontny U, Bertz H, Huzly D, Panning M. Falcone V, et al. Arch Virol. 2013 Jun;158(6):1297-303. doi: 10.1007/s00705-013-1610-1. Epub 2013 Feb 9. Arch Virol. 2013. PMID: 23397331 Free PMC article.
• Age-Dependent Glycomic Response to the 2009 Pandemic H1N1 Influenza Virus and Its Association with Disease Severity.
  Chen S, Kasper B, Zhang B, Lashua LP, Ross TM, Ghedin E, Mahal LK. Chen S, et al. J Proteome Res. 2020 Nov 6;19(11):4486-4495. doi: 10.1021/acs.jproteome.0c00455. Epub 2020 Oct 5. J Proteome Res. 2020. PMID: 32981324 Free PMC article.
• COVID-19: Antiviral agents and enzyme inhibitors/receptor blockers in development.
  Jogalekar MP, Veerabathini A, Patel AB. Jogalekar MP, et al. Exp Biol Med (Maywood). 2021 Jul;246(13):1533-1540. doi: 10.1177/1535370221999989. Epub 2021 Mar 23. Exp Biol Med (Maywood). 2021. PMID: 33757336 Free PMC article. Review.
• Differential Ability of Spike Protein of SARS-CoV-2 Variants to Downregulate ACE2.
  Maeda Y, Toyoda M, Kuwata T, Terasawa H, Tokugawa U, Monde K, Sawa T, Ueno T, Matsushita S. Maeda Y, et al. Int J Mol Sci. 2024 Jan 22;25(2):1353. doi: 10.3390/ijms25021353. Int J Mol Sci. 2024. PMID: 38279353 Free PMC article.
• Carbon-based glyco-nanoplatforms: towards the next generation of glycan-based multivalent probes.
  Ramos-Soriano J, Ghirardello M, Galan MC. Ramos-Soriano J, et al. Chem Soc Rev. 2022 Dec 12;51(24):9960-9985. doi: 10.1039/d2cs00741j. Chem Soc Rev. 2022. PMID: 36416290 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information